Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children

American Journal of Gastroenterology

Volumn 108, Issue 9, 2013, Pages 1526-1531

  Feldstein, Ariel E ^a   Alkhouri, Naim ^b   De Vito, Rita ^c   Alisi, Anna ^c   Lopez, Rocio ^b   Nobili, Valerio ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CHOLESTEROL; CYTOKERATIN 18; GAMMA GLUTAMYLTRANSFERASE; TRIACYLGLYCEROL;

APOPTOSIS; ARTICLE; BLOOD SAMPLING; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; FATTY LIVER; FEMALE; HUMANS; KERATIN-18; MALE; PEPTIDE FRAGMENTS; SEVERITY OF ILLNESS INDEX;

EID: 84883740164     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.168     Document Type: Article

References (29)

1. Angulo P. Nonalcoholic fatty liver disease. New Eng J Med 2002 ; 346 : 1221-31.
2. Brunt EM , Tiniakos DG. Pathological features of NASH. Front Biosci 2005 ; 10 : 1475-84.
3. Feldstein AE , Charatcharoenwitthaya P , Treeprasertsuk S et al. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009 ; 58 : 1538-44.
4. Wieckowska A , Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Seminars in Liver Disease 2008 ; 28 : 386-95.
5. Torres DM , Williams CD , Harrison SA. Features, diagnosis, and treatment of nonalcoholic Fatty liver disease. Clin Gastroenterol Hepatol 2012 ; 10 : 837-58.
6. Adams LA , Feldstein AE. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis. J Dig Dis 2011 ; 12 : 10-6.
7. Wieckowska A , Zein NN , Yerian LM et al. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology (Baltimore, Md) 2006 ; 44 : 27-33.
8. Alkhouri N , Carter-Kent C , Feldstein AE. Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications. Exp Rev Gastroenterol Hepatol 2011 ; 5 : 201-12.
9. Diab DL , Yerian L , Schauer P et al. Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. Clin Gastroenterol Hepatol 2008 ; 6 : 1249-54.
10. Yilmaz Y , Dolar E , Ulukaya E et al. Soluble forms of extracellular cytokeratin 18 may diff erentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol 2007 ; 13 : 837-44.
11. Younossi ZM , Page S , Rafi q N et al. A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fi brosis. Obes Surg 2011 ; 21 : 431-9.
12. Feldstein AE , Wieckowska A , Lopez AR et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 2009 ; 50 : 1072-8.
13. Kuczmarski RJ , Ogden CL , Grummer-Strawn LM et al. CDC growth charts: United States. Advance Data 2000 ; 314 : 1-27.
14. Cole TJ , Bellizzi MC , Flegal KM et al. Establishing a standard defi nition for child overweight and obesity worldwide: international survey. BMJ (Clinical Research ed) 2000 ; 320 : 1240-3.
15. Boney CM , Verma A , Tucker R et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005 ; 115 : e290-6.
16. Fernandez JR , Redden DT , Pietrobelli A et al. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediat 2004 ; 145 : 439-44.
17. American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992 ; 89 : 525-84.
18. Report of the Second Task Force on Blood Pressure Control in Children-1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 1987 ; 79 : 1-25.
19. Genuth S , Alberti KG , Bennett P et al. Follow-up report on the diagnosis of diabetes mellitus. Diab Care 2003 ; 26 : 3160-7.
20. Sanyal AJ , Brunt EM , Kleiner DE et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology (Baltimore, Md) 2011 ; 54 : 344-53.
21. Carter-Kent C , Yerian LM , Brunt EM et al. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study. Hepatology (Baltimore, Md) 2009 ; 50 : 1113-20.
22. Kleiner DE , Brunt EM , Van Natta M et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (Baltimore, Md) 2005 ; 41 : 1313-21.
23. Anty R , Iannelli A , Patouraux S et al. A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients. Aliment Pharmacol Therap 2010 ; 32 : 1315-22.
24. Malik R , Chang M , Bhaskar K et al. The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2009 ; 24 : 564-8.
25. Musso G , Gambino R , Durazzo M et al. Noninvasive assessment of liver disease severity with liver fat score and CK-18 in NAFLD: Prognostic value of liver fat equation goes beyond hepatic fat estimation. Hepatology (Baltimore, Md) 2010 ; 51 : 715-7.
26. Musso G , Gambino R , Cassader M et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011 ; 43 : 617-49.
27. Chalasani N , Younossi Z , Lavine JE et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology (Baltimore, Md) 2012 ; 55 : 2005-23.
28. Fitzpatrick E , Mitry RR , Quaglia A et al. Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fi brosis in paediatric NAFLD. J Pediat Gastroenterol Nutr 2010 ; 51 : 500-6.
29. Lebensztejn DM , Wierzbicka A , Socha P et al. Cytokeratin-18 and hyaluronic acid levels predict liver fi brosis in children with non-alcoholic fatty liver disease. Acta Biochimica Polonica 2011 ; 58 : 563-6.